BTMD vs. ACB, ADTH, MNMD, CDXC, MDWD, FTLF, OPAL, USNA, CGC, and CRON
Should you be buying biote stock or one of its competitors? The main competitors of biote include Aurora Cannabis (ACB), AdTheorent (ADTH), Mind Medicine (MindMed) (MNMD), ChromaDex (CDXC), MediWound (MDWD), FitLife Brands (FTLF), OPAL Fuels (OPAL), USANA Health Sciences (USNA), Canopy Growth (CGC), and Cronos Group (CRON).
biote (NASDAQ:BTMD) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk.
21.7% of biote shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 13.9% of biote shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
biote has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.96, meaning that its stock price is 96% more volatile than the S&P 500.
Aurora Cannabis received 368 more outperform votes than biote when rated by MarketBeat users. However, 100.00% of users gave biote an outperform vote while only 59.44% of users gave Aurora Cannabis an outperform vote.
In the previous week, Aurora Cannabis had 4 more articles in the media than biote. MarketBeat recorded 12 mentions for Aurora Cannabis and 8 mentions for biote. Aurora Cannabis' average media sentiment score of 0.80 beat biote's score of 0.47 indicating that Aurora Cannabis is being referred to more favorably in the news media.
biote has a net margin of 4.30% compared to Aurora Cannabis' net margin of -48.82%. Aurora Cannabis' return on equity of -23.27% beat biote's return on equity.
biote presently has a consensus target price of $8.11, suggesting a potential upside of 41.04%. Given biote's higher possible upside, analysts plainly believe biote is more favorable than Aurora Cannabis.
biote has higher revenue and earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks.
Summary
biote beats Aurora Cannabis on 10 of the 17 factors compared between the two stocks.
Get biote News Delivered to You Automatically
Sign up to receive the latest news and ratings for BTMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
